WINMED in The 40th World Congress of International Society of Hematology (ISH 2026), an international academic congress that brought together leading experts, researchers, physicians, and healthcare professionals from around the world to exchange knowledge and discuss the latest advancements in hematology, transfusion medicine, and medical innovation.

The congress featured comprehensive scientific discussions and presentations covering key areas in hematology, including blood disorders, diagnostic and treatment approaches, emerging medical technologies, and innovations related to blood safety—an increasingly important aspect in advancing patient care and healthcare quality.

WINMED’s participation reflects the company’s commitment to keeping pace with global medical developments and expanding perspectives through international knowledge exchange. Insights gained from the congress will contribute to strengthening the company’s capabilities in supporting advanced healthcare technologies and improving healthcare services in Thailand.

WINMED remains dedicated to continuous development and innovation, with the goal of supporting better healthcare outcomes and delivering sustainable improvements in patient care.